JTCS St. Jude Medical
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Faymonville, M. E.
Right arrow Articles by Lamy, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Faymonville, M. E.
Right arrow Articles by Lamy, M.

The Journal of Thoracic and Cardiovascular Surgery, Vol 91, 858-866, Copyright © 1986 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association


ARTICLES

Prostaglandin E2, prostacyclin, and thromboxane changes during nonpulsatile cardiopulmonary bypass in humans

ME Faymonville, G Deby-Dupont, R Larbuisson, C Deby, L Bodson, R Limet and M Lamy

To study the effect of lung bypass on the production of prostaglandin E2, prostacyclin, and thromboxane A2, we measured simultaneously arterial and venous plasma concentrations of prostaglandin E2, 6-keto- prostaglandin F1 alpha (stable metabolite of prostacyclin), and thromboxane B2 (stable metabolite of thromboxane A2) before, during, and after cardiopulmonary bypass. Seventeen patients (age range 46 to 69 years) undergoing aorta-coronary bypass grafts were investigated. The prostaglandin E2 production rose sharply immediately after the onset of bypass (baseline: 9.7 +/- 2.9 pg/ml to 85 +/- 16.6 pg/ml in venous and 87 +/- 12 pg/ml in arterial plasma, p less than 0.03) and rapidly decreased after pulmonary reperfusion (53 +/- 6.4 and 57 +/- 20 pg/ml, respectively, in venous and arterial plasma at the end of bypass). The increase in prostaglandin E2 was influenced by the heart- lung machine itself (as demonstrated by a closed "bypass" circuit) and by lung bypass. Pulmonary metabolism of prostaglandin E2 was maintained after bypass. The prostacyclin production rose significantly at the beginning of bypass (154 +/- 26 pg/ml venous prebypass level to 361 +/- 94 pg/ml after aortic clamping, p less than 0.03). Prostacyclin decreased progressively during rewarming of the patient, pulmonary reperfusion, and discontinuation of bypass. When prostacyclin decreased, thromboxane B2 production rose significantly and reached peak arterial levels when the lungs were reperfused (112 +/- 33 pg/ml prebypass levels to 402 +/- 101 pg/ml, p less than 0.01). Except for prostaglandin E2, there were no significant differences between arterial and venous plasma levels of these substances. The same prostanoids were also measured in five patients undergoing major orthopedic operations, and no significant changes in prostanoids were observed. Our data demonstrate significant production of prostaglandin E2 in the systemic circulation during cardiopulmonary bypass in humans. They further indicate that lung bypass disturbs the plasma prostaglandin/thromboxane balance.


This article has been cited by other articles:


Home page
Card Surg AdultHome page
J. W. Hammon
Extracorporeal Circulation: The Response of Humoral and Cellular Elements of Blood to Extracorporeal Circulation
Card. Surg. Adult, January 1, 2008; 3(2008): 370 - 389.
[Full Text]


Home page
Asian Cardiovasc. Thorac. Ann.Home page
S. A Hassantash, G. R Omrani, N. Givtaj, and M. Afrakhteh
Pharmacological Prevention of the Deleterious Effects of Cardiopulmonary Bypass
Asian Cardiovasc Thorac Ann, June 1, 2007; 15(3): 218 - 224.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
M. Arshad, V. Vijay, B. C. Floyd, B. Marks, M. R. Sarabu, M. S. Wolin, and S. A. Gupte
Thromboxane Receptor Stimulation Suppresses Guanylate Cyclase-Mediated Relaxation of Radial Arteries
Ann. Thorac. Surg., June 1, 2006; 81(6): 2147 - 2154.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
N. A. Nussmeier, A. A. Whelton, M. T. Brown, R. M. Langford, A. Hoeft, J. L. Parlow, S. W. Boyce, and K. M. Verburg
Complications of the COX-2 Inhibitors Parecoxib and Valdecoxib after Cardiac Surgery
N. Engl. J. Med., March 17, 2005; 352(11): 1081 - 1091.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
C. W. Honemann, K. Hahnenkamp, T. Podranski, D. Strumper, M. W. Hollmann, and M. E. Durieux
Local Anesthetics Inhibit Thromboxane A2 Signaling in Xenopus Oocytes and Human K562 Cells
Anesth. Analg., September 1, 2004; 99(3): 930 - 937.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J. N. Fain, A. K. Madan, M. L. Hiler, P. Cheema, and S. W. Bahouth
Comparison of the Release of Adipokines by Adipose Tissue, Adipose Tissue Matrix, and Adipocytes from Visceral and Subcutaneous Abdominal Adipose Tissues of Obese Humans
Endocrinology, May 1, 2004; 145(5): 2273 - 2282.
[Abstract] [Full Text] [PDF]


Home page
Card Surg AdultHome page
L. H. Edmunds Jr. and R. W. Colman
Extracorporeal Circulation: Thrombosis and Bleeding
Card. Surg. Adult, January 1, 2003; 2(2003): 338 - 348.
[Full Text]


Home page
Card Surg AdultHome page
P. Menasche and L. H. Edmunds Jr.
Extracorporeal Circulation: The Inflammatory Response
Card. Surg. Adult, January 1, 2003; 2(2003): 349 - 360.
[Full Text]


Home page
Ann. Thorac. Surg.Home page
M. Nagashima, Y. Imai, K. Seo, M. Terada, M. Aoki, T. Shin'oka, and M. Koide
Effect of hemofiltrated whole blood pump priming on hemodynamics and respiratory function after the arterial switch operation in neonates
Ann. Thorac. Surg., December 1, 2000; 70(6): 1901 - 1906.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
T. Ohata, Y. Sawa, K. Kadoba, T. Masai, H. Ichikawa, and H. Matsuda
Effect of Cardiopulmonary Bypass Under Tepid Temperature on Inflammatory Reactions
Ann. Thorac. Surg., July 1, 1997; 64(1): 124 - 128.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
P. M. Kirshbom, S. O. Page, M. T. Jacobs, S. S. L. Tsui, E. Bello, R. M. Ungerleider, D. A. Schwinn, and J. W. Gaynor
CARDIOPULMONARY BYPASS AND CIRCULATORY ARREST INCREASE ENDOTHELIN-1 PRODUCTION AND RECEPTOR EXPRESSION IN THE LUNG
J. Thorac. Cardiovasc. Surg., April 1, 1997; 113(4): 777 - 783.
[Abstract] [Full Text]


Home page
CirculationHome page
V. M. Reddy, K. D. Hendricks-Munoz, H. A. Rajasinghe, E. Petrossian, F. L. Hanley, and J. R. Fineman
Post–Cardiopulmonary Bypass Pulmonary Hypertension in Lambs With Increased Pulmonary Blood Flow: A Role for Endothelin 1
Circulation, February 18, 1997; 95(4): 1054 - 1061.
[Abstract] [Full Text]


Home page
Ann. Thorac. Surg.Home page
V. M. Reddy, J. R. Liddicoat, J. R. Klein, D. B. McElhinney, R. K. Wampler, and F. L. Hanley
Fetal Cardiac Bypass Using an In-Line Axial Flow Pump to Minimize Extracorporeal Surface and Avoid Priming Volume
Ann. Thorac. Surg., August 1, 1996; 62(2): 393 - 400.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
Y. J. Gu, A. J. deVries, P. W. Boonstra, and W. van Oeveren
LEUKOCYTE DEPLETION RESULTS IN IMPROVED LUNG FUNCTION AND REDUCED INFLAMMATORY RESPONSE AFTER CARDIAC SURGERY
J. Thorac. Cardiovasc. Surg., August 1, 1996; 112(2): 494 - 500.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
K. E. Wehberg, A. H. Foster, R. M. Wise, J. S. McLaughlin, and M. J. Brunner
NITRIC OXIDE MEDIATES FLUID ACCUMULATION DURING CARDIOPULMONARY BYPASS
J. Thorac. Cardiovasc. Surg., July 1, 1996; 112(1): 168 - 174.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
P. M. Kirshbom, M. T. Jacobs, S. S. L. Tsui, L. R. DiBernardo, D. A. Schwinn, R. M. Ungerleider, and J. W. Gaynor
EFFECTS OF CARDIOPULMONARY BYPASS AND CIRCULATORY ARREST ON ENDOTHELIUM-DEPENDENT VASODILATATION IN THE LUNG
J. Thorac. Cardiovasc. Surg., June 1, 1996; 111(6): 1248 - 1256.
[Abstract] [Full Text]


Home page
Ann. Thorac. Surg.Home page
M. Friedman, S. Y. Wang, F. W. Sellke, A. Franklin, R. M. Weintraub, and R. G. Johnson
Pulmonary Injury After Total or Partial Cardiopulmonary Bypass With Thromboxane Synthesis Inhibition
Ann. Thorac. Surg., March 1, 1995; 59(3): 598 - 603.
[Abstract] [Full Text]


Home page
PerfusionHome page
H. Komai and S. G Haworth
The effect of cardiopulmonary bypass on the lung: the injured pulmonary vascular endothelium
Perfusion, January 1, 1993; 8(1): 55 - 62.
[PDF]


Home page
ANGIOLOGYHome page
P. J. A. van der Starre, R. S. Reneman, and H. W. Scheijgrond
Ketanserin in the Treatment of Systemic Hypertension During and Following Coronary Artery Bypass Surgery
Angiology, November 1, 1989; 40(11): 1001 - 1010.
[Abstract] [PDF]


Home page
PerfusionHome page
W. van Oeveren and C. Wildevuur
Review article : Blood compatibility of cardiopulmonary bypass circuits
Perfusion, October 1, 1987; 2(4): 237 - 244.
[PDF]


Home page
PerfusionHome page
P. Boonstra, F. Vermeulen, J. Leusink, E. de Nooy, A. van Zalk, J. Soons, and C. Wildevuur
Platelet damage and haemolysis during bubble oxygenator perfusion with and without arterial line filter, compared to membrane oxygenator perfusion
Perfusion, January 1, 1987; 2(1): 27 - 33.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1986 by The American Association for Thoracic Surgery.